Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their ...

Medical device specialist Medtronic ( MDT 1.05%) has long been a solid dividend stock -- and it has upped its payout for ...

The U.S. Food and Drug Administration has approved Medtronic's MiniMed Paradigm insulin pump, which is also a glucose monitor. The U.S. Food and Drug Administration has approved Medtronic's ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...

Medtronic Plc is a medical technology company ... The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded ...

Shares of Medtronic (MDT) traded marginally lower on Thursday after rising from a low of $80.01 from the past six trading sessions, where shares soared overall ...

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).